01—Abstract
Summary
Summary of the 8-K filed May 6, 2025. Cited figures are marked; the original filing is the authoritative source.
Jacobs Solutions Inc. (NYSE: J) reported results for its fiscal second quarter ended March 28, 2025, in a press release furnished as Exhibit 99.1.
Gross revenue was $2.91 billiona, up from $2.85 billion a year earlier, and adjusted net revenue was $2.14 billion versus $2.07 billion. GAAP net earnings from continuing operations fell sharply to $11.2 million ($0.10 per diluted share) from $92.2 million ($0.73 per share), mainly because of a $109.5 million mark-to-market loss on the company's Amentum (AMTM) investment and a reserve following an unfavorable interim ruling against a consolidated joint venture in which Jacobs holds a 50% interest. Adjusted EPS from continuing operations was $1.43, compared with $1.17, and adjusted EBITDA was $286.6 million, compared with $265.0 million.
Backlog reached $22.16 billionb, up from $18.47 billion a year earlier, and the release cites a trailing-twelve-month book-to-bill ratio of 1.3x. The company repurchased $350.8 million of its shares in the quarter and $552.4 million in the first half of fiscal 2025.
It also completed an equity-for-debt exchange using its Amentum stake, which the release says retired $312 millionc of debt, and refinanced about $700 million of debt at a lower rate. Jacobs reaffirmed its fiscal 2025 guidance, including adjusted EPS of $5.85 to $6.20 and an adjusted EBITDA margin of 13.8% to 14.0%, and said the Board approved distributing the remaining Amentum shares to shareholders on May 30.
02—Key points
Key Highlights
- Gross revenue of $2.91 billion, up from $2.85 billion; adjusted net revenue of $2.14 billion, up from $2.07 billion.
- GAAP EPS from continuing operations of $0.10, down from $0.73, driven by a $109.5 million mark-to-market loss on the Amentum investment and a reserve tied to an interim ruling against a consolidated JV.
- Adjusted EPS from continuing operations of $1.43, up from $1.17; adjusted EBITDA of $286.6 million, up from $265.0 million.
- Backlog of $22.16 billion, up from $18.47 billion a year earlier; quarterly book-to-bill of 1.1x and 1.3x on a trailing-twelve-month basis.
- Share repurchases of $350.8 million in the quarter and $552.4 million in the first half of fiscal 2025.
- Equity-for-debt exchange using the Amentum stake retired $312 million of debt; about $700 million of debt was refinanced at a lower interest rate.
- Fiscal 2025 guidance reaffirmed: adjusted EPS of $5.85 to $6.20, adjusted EBITDA margin of 13.8% to 14.0%, and reported FCF conversion above 100% of net income.
03—Questions
Frequently Asked Questions
Why did GAAP earnings fall so sharply this quarter?
GAAP net earnings from continuing operations dropped to $11.2 million, or $0.10 per diluted share, from $92.2 million, or $0.73. The release attributes this mainly to a $109.5 million mark-to-market loss on the Amentum stock investment and a reserve following an unfavorable interim ruling against a consolidated joint venture in which the company holds a 50% interest.
How did the core business perform?
Gross revenue rose to $2.91 billion from $2.85 billion, and adjusted net revenue rose to $2.14 billion from $2.07 billion. Adjusted EBITDA increased to $286.6 million from $265.0 million, and adjusted EPS increased to $1.43 from $1.17. Management cited strong Life Sciences, Transportation, and Energy & Power growth within Infrastructure & Advanced Facilities, and PA Consulting revenue growth of 5% in the quarter.
How much capital did Jacobs return to shareholders?
The company repurchased $350.8 million of shares in the quarter and $552.4 million in the first half of fiscal 2025. Cash dividends to shareholders were $39.4 million in the quarter and $75.9 million for the first half.
What is the outlook for fiscal 2025?
Jacobs reaffirmed its fiscal 2025 outlook: adjusted net revenue growth in the mid-to-high single digits over fiscal 2024, an adjusted EBITDA margin of 13.8% to 14.0%, reported free cash flow conversion above 100% of net income, and adjusted EPS of $5.85 to $6.20.
What happens with the remaining Amentum shares?
After the quarter closed, the company finalized the post-closing working capital adjustment for the separation of its former CMS and C&I businesses, which enables additional debt reduction in the third quarter of fiscal 2025. The Board approved distributing the remaining Amentum shares to Jacobs shareholders on May 30, 2025.
04—Continue